Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Blood Purification for the Treatment of Patients With Septic Shock: a Multicenter, Open-label, Randomized, Parallel Controlled Study

NCT06692036 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT06692036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Blood Purification for the Treatment of Patients With Septic Shock: a Multicenter, Open-label, Randomized, Parallel Controlled Study
Lead sponsor
Beijing Chao Yang Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
276 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock